| 000 | 00738nam a22002417a 4500 | ||
|---|---|---|---|
| 008 | 230705b |||||||| |||| 00| 0 eng d | ||
| 020 | _a978-92-9497-865-3 | ||
| 040 | _cVAD | ||
| 041 | _aEngels | ||
| 110 | _aEuropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA) | ||
| 245 | _aEuropean Drug Report 2023: Trends and Developments [PDF] | ||
| 260 |
_aLissabon _bEMCDDA _c2023 |
||
| 300 | _awebpagina | ||
| 650 | _a buprenorfine | ||
| 650 | _adrugs | ||
| 650 | _aepidemiologie | ||
| 650 | _aEuropa | ||
| 650 | _ajustitiabele druggebruikers | ||
| 650 | _aonderzoeksrapporten | ||
| 650 | _acannabis | ||
| 650 | _acocaïne | ||
| 856 | _uhttps://www.google.com/search?q=European_Drug_Report_2023:_Trends_and_Developments | ||
| 999 |
_c21736 _d21736 |
||